World Top 1,000 Companies as of January 2024
World Rank (Jan-05-2024)
12,544
World Rank (Jul-30-2023)
12,544
Market Cap (Jul-30-2023)
0.517 Billion USD
World Rank (Dec-25-2022)
14,164
Market Cap (Dec-25-2022)
0.383 Billion USD
World Rank (Jan-05-2024)
12,545
World Rank (Jul-30-2023)
12,545
Market Cap (Jul-30-2023)
0.517 Billion USD
World Rank (Dec-25-2022)
28,444
Market Cap (Dec-25-2022)
0.025 Billion USD
World Rank (Jan-05-2024)
12,545
Market Cap (Jan-05-2024)
0.505 Billion USD
World Rank (Jul-30-2023)
13,490
Market Cap (Jul-30-2023)
0.445 Billion USD
World Rank (Dec-25-2022)
14,299
Market Cap (Dec-25-2022)
0.376 Billion USD
World Rank (Jan-07-2022)
13,438
Market Cap (Jan-07-2022)
0.50 Billion USD
Annual Revenue in USD
66 Million USD
Annual Net Income in USD
15 Million USD
Annual Results for Period Ending
Mar-2022 ending year
World Rank (Jan-05-2024)
12,546
Market Cap (Jan-05-2024)
0.504 Billion USD
World Rank (Jul-30-2023)
13,325
Market Cap (Jul-30-2023)
0.456 Billion USD
World Rank (Dec-25-2022)
13,193
Market Cap (Dec-25-2022)
0.443 Billion USD
World Rank (Jan-07-2022)
11,953
Market Cap (Jan-07-2022)
0.64 Billion USD
World Rank (Jan-05-2024)
12,547
Market Cap (Jan-05-2024)
0.504 Billion USD
World Rank (Jul-30-2023)
12,933
Market Cap (Jul-30-2023)
0.486 Billion USD
World Rank (Dec-25-2022)
12,840
Market Cap (Dec-25-2022)
0.468 Billion USD
World Rank (Jan-07-2022)
11,325
Market Cap (Jan-07-2022)
0.72 Billion USD
World Rank (Jan-05-2024)
12,548
Market Cap (Jan-05-2024)
0.504 Billion USD
World Rank (Jul-30-2023)
8,448
Market Cap (Jul-30-2023)
1.061 Billion USD
World Rank (Dec-25-2022)
9,806
Market Cap (Dec-25-2022)
0.768 Billion USD
World Rank (Jan-07-2022)
16,133
Market Cap (Jan-07-2022)
0.33 Billion USD
Company Profile
Cogent Biosciences, Inc is a biotechnology company developing real solutions to treat genetically driven diseases. The headquarters is in USA.
Facts About Company
Cogent Biosciences, Inc Annual Net loss for year ending Dec-2022 was -140 million USD.
Cogent Biosciences, Inc Annual Net loss for year ending Dec-2021 was -72 million USD.
As on 2022, Cogent Biosciences, Inc has 138 employees.
World Rank (Jan-05-2024)
12,549
Market Cap (Jan-05-2024)
0.504 Billion USD
World Rank (Jul-30-2023)
11,364
Market Cap (Jul-30-2023)
0.624 Billion USD
World Rank (Dec-25-2022)
10,351
Market Cap (Dec-25-2022)
0.700 Billion USD
World Rank (Jan-07-2022)
12,177
Market Cap (Jan-07-2022)
0.62 Billion USD
World Rank (Jan-05-2024)
12,549
World Rank (Jul-30-2023)
12,549
World Rank (Dec-25-2022)
12,549
World Rank (Jan-07-2022)
12,549
World Rank (Jan-05-2024)
12,550
Market Cap (Jan-05-2024)
0.504 Billion USD
World Rank (Jul-30-2023)
11,658
Market Cap (Jul-30-2023)
0.595 Billion USD
World Rank (Dec-25-2022)
17,785
Market Cap (Dec-25-2022)
0.209 Billion USD
World Rank (Jan-07-2022)
15,346
Market Cap (Jan-07-2022)
0.37 Billion USD
World Rank (Jan-05-2024)
12,551
Market Cap (Jan-05-2024)
0.504 Billion USD
World Rank (Jul-30-2023)
12,270
Market Cap (Jul-30-2023)
0.538 Billion USD
World Rank (Dec-25-2022)
10,845
Market Cap (Dec-25-2022)
0.644 Billion USD
World Rank (Jan-07-2022)
12,186
Market Cap (Jan-07-2022)
0.61 Billion USD
Annual Revenue in USD
13,626 Million USD
Annual Net Income in USD
22,410 Million USD
Annual Results for Period Ending
Dec-2020 ending year